Copolymer-based Nanoparticles Research Articles

Novel pentablock copolymer (PLA–PCL–PEG–PCL–PLA)-based nanoparticles for controlled drug delivery: effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles

The purpose of this investigation was to design novel pentablock copolymers (polylatide-polycaprolactone-polyethylene glycol- polycaprolactone-polylatide) (PLA-PCL-PEG-PCL-PLA) to prepare nanoparticle formulations which provide continuous delivery of steroids over a longer duration with minimal burst effect. Another purpose was to evaluate the effect of poly (L-lactide) (PLLA) or poly (D, L-lactide) (PDLLA) incorporation on crystallinity of pentablock copolymers and in vitro release profile of triamcinolone acetonide (selected as model drug) from nanoparticles. PLA-PCL-PEG-PCL-PLA copolymers with different block ratio of PCL/PLA segment were synthesized. Release of triamcinolone acetonide from nanoparticles was significantly affected by crystallinity of the copolymers. Burst release of triamcinolone acetonide from nanoparticles was significantly minimized with incorporation of proper ratio of PDLLA in the existing triblock (PCL-PEG-PCL) copolymer. Moreover, pentablock copolymer based nanoparticles exhibited continuous release of triamcinolone acetonide. Pentablock copolymer based nanoparticles can be utilized to achieve continuous near zero-order delivery of corticosteroids from nanoparticles without any burst effect.

In vitro ageing and degradation of PEG–PLA diblock copolymer-based nanoparticles

Diblock copolymers composed of poly(oxy-ethylene) (POE) and poly( dl-lactic acid) segments were synthesized by anionic polymerization of d, l-lactide using the oxyanion formed by reaction of the monohydroxyl monomethoxy-poly(ethylene glycol) on sodium hydride. For comparison, a similar copolymer was prepared by using tin octoate to catalyze the lactide polymerization. The copolymers were used to make nanoparticles, which were stored at 4 °C. After a few months under these storage conditions, a dramatic decrease of the poly(ethylene glycol) content was observed, however, the mean diameter of the nanoparticles was not affected. The degradation of the nanoparticles was investigated in vitro under conditions selected to mimic physiological conditions. Changes of characteristics were monitored by 1H NMR, SEC, DLLS and CZE on nanoparticles and/or on the degradation by-products dissolved in the ageing medium. According to their nanometric dimensions, the microparticles degraded very slowly and there was no difference in behaviour between the sodium hydride and the stannous octoate-derived copolymers.